FDA Submits Blood Establishment Registration and Product Listing Information Collection for OMB Review

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, which will require blood establishments to register and list their products.